Skip to main content
. 2017 Dec 27;12(12):e0190218. doi: 10.1371/journal.pone.0190218

Table 2. Outcome analysis.

Acute Stenting with Tirofiban n = 60 Acute MCA thrombectomy without Tirofiban n = 135 After propensity score adjustment, OR with CI and p-value
Discharge mRS 0–3 32 (53%) 60 (44%) OR 3.164 [1.306–7.668]; p = 0.011
90 days mRS 0–3 37 (62%) 66 (49%) OR 2.129 [0.930–4.872]; p = 0.074
Reinfarction 2 (3%) 1 (1%) n.a.*
Any ICH 12 (20%) 27 (20%) OR 0.863 [0.370–2.013]; p = 0.734
Symptomatic ICH 5 (8%) 8 (6%) OR 1.706 [0.388–7.505]; p = 0.480
Death within hospital stay 6 (10%) 14 (10%) OR 3.292 [0.797–13.597]; p = 0.100

* numbers to small